View by Specialty

Trending

C auris investigation Matthew Stuckey CDC
October 15, 2025
4 min read
Save

CDC staffers fired due to ‘glitch’ are reinstated

Headline News

SPONSORED CONTENT
October 21, 2025
2 min read
Save
Persistent pesticide exposure may increase rheumatoid arthritis risk in women

Persistent pesticide exposure may increase rheumatoid arthritis risk in women

Persistent exposure to certain insecticides and pesticides may increase the risk for rheumatoid arthritis among women, according to findings published in Arthritis & Rheumatology.

SPONSORED CONTENT
October 20, 2025
2 min read
Save

Shingles vaccination lowers risk for heart disease, dementia, death

Shingles vaccination lowers risk for heart disease, dementia, death

ATLANTA — There is more evidence that shingles vaccination significantly decreases the risk for heart disease, dementia and death among people aged 50 years or older with herpes zoster infection, according to data presented at IDWeek.

SPONSORED CONTENT
October 20, 2025
1 min read
Save

Young ophthalmologists should not ignore ergonomics

Young ophthalmologists should not ignore ergonomics

ORLANDO — Younger ophthalmologists need to hear the message of proper ergonomics as early as possible, according to a speaker at the American Academy of Ophthalmology meeting.

Trending

C auris investigation Matthew Stuckey CDC
October 15, 2025
4 min read
Save

CDC staffers fired due to ‘glitch’ are reinstated

SPONSORED CONTENT
October 20, 2025
5 min read
Save

Exa-cel dramatically improves quality of life for sickle cell disease, beta-thalassemia

Exa-cel dramatically improves quality of life for sickle cell disease, beta-thalassemia

Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and long-term improvements in quality of life, including pain reduction and physical and emotional well-being.

SPONSORED CONTENT
October 20, 2025
2 min read
Save

Roflumilast more beneficial than azithromycin for COPD exacerbations, not mortality

Roflumilast more beneficial than azithromycin for COPD exacerbations, not mortality

CHICAGO — Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but heightened all-cause mortality, according to results presented at the CHEST Annual Meeting.

SPONSORED CONTENT
October 20, 2025
1 min read
Save

Bone quality markers may improve future interventions for noninflammatory ankle OA

Bone quality markers may improve future interventions for noninflammatory ankle OA

Differences in bone quality between nonarthritic and arthritic ankles may illuminate future intervention strategies for ankle OA, according to data presented at the American Orthopaedic Foot & Ankle Society Annual Meeting.

SPONSORED CONTENT
October 20, 2025
2 min read
Save

BLOG: The coming phases of AI’s disruption of health care

BLOG: The coming phases of AI’s disruption of health care

Every medical innovation is usually met with both some excitement and some appropriate skepticism.

SPONSORED CONTENT
October 20, 2025
1 min read
Save

Study: C. difficile more deadly among white patients, females

Study: <i>C. difficile </i>more deadly among white patients, females

ATLANTA — Rates of deaths attributed to Clostridioides difficile infection are higher among white patients, females and patients in metropolitan areas, according to data presented at IDWeek.

SPONSORED CONTENT
October 20, 2025
2 min read
Save

GLP-1s, fenofibrates reduce risk for diabetic macular edema

GLP-1s, fenofibrates reduce risk for diabetic macular edema

GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, according to a study published in Ophthalmology Retina.

SPONSORED CONTENT
October 20, 2025
2 min read
Save

FDA approves Gazyva for lupus nephritis, marking ‘significant advancement’ for patients

FDA approves Gazyva for lupus nephritis, marking &lsquo;significant advancement&rsquo; for patients

The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving standard therapy, making it the second biologic available for patients with the disease.

View more